Theratechnologies Inc.
TH.TO
TSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.02% | 5.75% | 3.62% | -4.06% | 2.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.02% | 5.75% | 3.62% | -4.06% | 2.13% |
| Cost of Revenue | 4.14% | -5.18% | -4.51% | -14.49% | -17.63% |
| Gross Profit | 5.29% | 9.52% | 6.49% | 0.21% | 10.51% |
| SG&A Expenses | -1.18% | 3.22% | 0.32% | -19.61% | -17.34% |
| Depreciation & Amortization | -42.70% | -72.72% | -72.72% | -75.91% | -78.43% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.08% | -26.65% | -26.30% | -29.74% | -24.62% |
| Operating Income | 194.34% | 162.55% | 123.31% | 85.36% | 78.29% |
| Income Before Tax | 73.23% | 92.66% | 81.46% | 63.52% | 49.70% |
| Income Tax Expenses | 376.25% | 115.27% | -17.25% | -15.04% | -4.97% |
| Earnings from Continuing Operations | 65.33% | 89.16% | 80.53% | 63.01% | 49.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.33% | 89.16% | 80.53% | 63.01% | 49.28% |
| EBIT | 194.34% | 162.55% | 123.31% | 85.36% | 78.29% |
| EBITDA | 285.90% | 191.71% | 140.45% | 89.01% | 79.54% |
| EPS Basic | 82.47% | 92.35% | 87.57% | 69.58% | 51.62% |
| Normalized Basic EPS | 98.91% | 101.58% | 93.75% | 73.13% | 62.05% |
| EPS Diluted | 82.20% | 92.13% | 87.57% | 69.58% | 51.62% |
| Normalized Diluted EPS | 98.91% | 101.58% | 93.75% | 73.13% | 62.05% |
| Average Basic Shares Outstanding | 87.46% | 87.34% | 61.97% | 36.39% | 10.58% |
| Average Diluted Shares Outstanding | 87.47% | 87.36% | 61.98% | 36.39% | 10.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
